Founder Stories: Arie Belldegrun, Founder of Kite Pharma

Arie Belldegrun is the Co-Founder of Kite Pharma, Allogene Therapeutics, and countless other biotechnology companies as well as a Professor of Urology at UCLA. His career has spanned work in immunotherapy, urology, surgery, and cell therapies. Kite Pharma was able to get the second CAR-T cell therapy approved after Novartis, and now Allogene is positioned to get the first allogeneic CAR-T approved.
axialobservati...
#biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders #founderstory #scienceandtechnology #sciencestory #stories #bioengineering #engineering #engineer #biochemistry #discovery #discover #technical #health #education #educational #learning #learn #podcast #podcasts #podcasting #podcaster #technews
Axial Newsletter: axial.substack...
Build with Axial: axial22.axialv...

[@dreamlife4344]

I have always been interested in immunotherapy, my ancestors also come from the Beldegrun family. I think that in the future it will be possible to transfer genes and change the code of mutating cells

[@marthaellenconner98]

♥️T cells immunotherapy ♥️

[@marthaellenconner98]

🤍T cells immunotherapy ♥️